Related Experiment Video
Updated: Mar 15, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
(18)F-Fluorodeoxyglucose PET/MR Imaging in Lymphoma.
1Department of Radiology, Dresden University Hospital, Fetscherstr. 74, Dresden 01307, Germany.
(18)F-Fluorodeoxyglucose (FDG) PET/MR imaging is feasible for initial staging and therapy response assessment in lymphoma. More data are needed for other indications, and diffusion-weighted MR imaging requires further systematic evaluation.
Area of Science:
- Oncology
- Radiology
- Nuclear Medicine
Background:
- (18)F-Fluorodeoxyglucose (FDG) PET/MR imaging is a viable tool for lymphoma staging and treatment response evaluation.
- FDG PET/MR imaging shows comparable initial staging performance to FDG PET/CT in lymphoma patients.
Purpose of the Study:
- To assess the feasibility of (18)F-Fluorodeoxyglucose (FDG) PET/MR imaging for initial staging and therapy response assessment in lymphoma.
- To evaluate the current data supporting FDG PET/MR imaging for various lymphoma indications.
- To highlight the potential of diffusion-weighted MR imaging as an adjunct to FDG PET/MR imaging.
Main Methods:
- Utilized (18)F-Fluorodeoxyglucose (FDG) PET/MR imaging for lymphoma staging and response assessment.
- Compared FDG PET/MR imaging with FDG PET/CT for initial staging.
- Reviewed existing literature on FDG PET/MR imaging in lymphoma.
Main Results:
- FDG PET/MR imaging is feasible for initial staging and therapy response assessment in lymphoma.
- FDG PET/MR imaging is equivalent to FDG PET/CT for initial lymphoma staging.
- Limited data exist for other indications of FDG PET/MR imaging in lymphoma.
Conclusions:
- FDG PET/MR imaging is a feasible modality for lymphoma staging and response assessment.
- Further research is needed to establish the role of FDG PET/MR imaging in broader lymphoma indications.
- Systematic evaluation of diffusion-weighted MR imaging in conjunction with FDG PET/MR imaging is warranted.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
11:34Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT
Published on: April 29, 2017
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET